Log In
Print
BCIQ
Print
Print this Print this
 

DT-200 (formerly GLPG0492)

Also known as: SARM compound

  Manage Alerts
Collapse Summary General Information
Company Galapagos N.V.
DescriptionSelective androgen receptor modulator (SARM)
Molecular Target Androgen receptor
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationMuscular dystrophy
Indication DetailsTreat Duchenne muscular dystrophy (DMD)
Regulatory Designation

Partner

Akashi Therapeutics Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today